Abstract
Objective
In this study, we investigated the interrelationship between clinicopathologic findings and pre-B-cell leukemia transcription factor 2 (PBX2) expression in gingival squamous cell carcinoma (GSCC).
Methods
Expression level of PBX2 was immunohistochemically examined in 66 GSCC subjects (30 men and 36 women) with ages ranging from 42 to 85 (median 64.5) years, in which staining intensity in tumor cells was categorized as either weaker (level 1) or equal to/stronger (level 2) than that in the endothelial cells.
Results
PBX2 expression is correlated with valosin-containing protein (VCP) expression. Univariate and multivariate analyses revealed a high level of PBX2 expression to be a poor prognosticator for disease-free survival (DFS) and overall survival (OS), and PBX2 expression was an independent prognostic factor for both DFS and OS in GSCC.
Conclusions
PBX2 expression level in GSCC is prognostic. PBX2 may be a useful marker to identify the potential for progression in GSCC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Byers, R.M., White, D., Yue, A., 1981. Squamous carcinoma of the oral cavity: choice of therapy. Curr. Probl. Cancer, 6(5):1–27. [doi:10.1016/S0147-0272(81)80015-3]
Cox, D.R., 1972. Regression models and life tables. J. Roy Stat. Soc., 34(3):187–220.
Eicher, S.A., Clayman, G.L., Liu, T.J., Shillitoe, E.J., Storthz, K.A., Roth, J.A., Lotan, R., 1996. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model. Clin. Cancer Res., 2(10): 1659–1664.
Gomez, D., Faucher, A., Picot, V., Siberchicot, F., Renaud-Salis, J.L., Bussières, E., Pinsolle, J., 2000. Outcome of squamous cell carcinoma of the gingiva: a follow-up study of 83 cases. J. Craniomaxillofac. Surg., 28(6): 331–335. [doi:10.1054/jcms.2000.0177]
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., Thun, M.J., 2003. Cancer statistics 2003. CA-Cancer J. Clin., 53(1):5–26. [doi:10.3322/canjclin.53.1.5]
Kamps, M.P., Look, A.T., Baltimore, D., 1991. The human t(1; 19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev., 5(3):358–368. [doi:10.1101/gad.5.3.358]
Kaplan, E.L., Meier, P., 1958. Non-parametric estimation for incomplete observations. J. Am. Stat. Assoc., 53(282): 457–481. [doi:10.2307/2281868]
Levi, P.A.Jr., Kim, D.M., Harsfield, S.L., Jacobson, E.R., 2005. Squamous cell carcinoma presenting as an endodontic-periodontic lesion. J. Periodontol., 76(10):1798–1804. [doi:10.1902/jop.2005.76.10.1798]
Lippman, S.M., Hong, W.K., 2001. Molecular markers of the risk of oral cavity. N. Engl. J. Med., 344(17):1323–1326. [doi:10.1056/NEJM200104263441710]
Longobardi, E., Blasi, F., 2003. Overexpression of PREP-1 in F9 teratocarcinoma cells leads to a functionally relevant increase of PBX-2 by preventing its degradation. J. Biol. Chem., 278(40):39235–39241. [doi:10.1074/jbc.M304704200]
Mann, R.S., Affolter, M., 1998. Hox proteins meet more partners. Curr. Opin. Genet. Dev., 8(4):423–429. [doi:10.1016/S0959-437X(98)80113-5]
Naora, H., Yang, Y.Q., Montz, F.J., Seidman, J.D., Kurman, R.J., Roden, R.B., 2001. A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. PNAS, 98(7):4060–4065. [doi: 10.1073/pnas.071594398]
Phelan, M.L., Rambaldi, I., Featherstone, M.S., 1995. Cooperative interactions between Hox and Pbx proteins mediated by a conserved peptide motif. Mol. Cell Biol., 15(8): 3989–3997.
Plowright, L., Harrington, K.J., Pandha, H.S., Morgan, R., 2009. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br. J. Cancer, 100(3):470–475. [doi:10.1038/sj.bjc.6604857]
Qiu, Y., Tomita, Y., Zhang, B.L., Nakamichi, I., Morii, E., Aozasa, K., 2007. Pre-B-cell leukemia transcription factor 1 regulates expression of valosin-containing protein, a gene involved in cancer growth. Am. J. Pathol., 170(1): 152–159. [doi:10.2353/ajpath.2007.060722]
Qiu, Y., Morii, E., Tomita, Y., Zhang, B.L., Matsumura, A., Kitaichi, M., Okumura, M., Aozasa, K., 2009. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma. Cancer Sci., 100(7):1198–1209. [doi:10.1111/j.1349-7006.2009.01156.x]
Qiu, Y., Song, B., Zhao, G.F., Deng, B.Y., Makino, T., Tomita, Y., Wang, J.C., Luo, W.J., Doki, Y., Aozasa, K., et al., 2010. Expression level of pre B cell leukemia homeobox 2 (PBX2) correlates with poor prognosis of gastric adenocarcinoma and esophageal squamous cell carcinoma. Int. J. Oncol., 36(3):651–663. [doi:10.3892/ijo_00000541]
Randhawa, T., Shameena, P.M., Sudha, S., Nair, R.G., 2008. Squamous cell carcinoma of tongue in a 19-year-old female. Indian J. Cancer, 45(3):128–130. [doi:10.4103/0019-509X.44071]
Shaw, R.J., McGlashan, G., Woolgar, J.A., Lowe, D., Brown, J.S., Vaughan, E.D., Rogers, S.N., 2009. Prognostic importance of site in squamous cell carcinoma of the buccal mucosa. Br. J. Oral Maxillofac. Surg., 47(5):356–359. [doi:10.1016/j.bjoms.2008.09.017]
Sobin, L.H., Wittekind, C.H., 2002. TNM Classification of Malignant Tumours, 6th Ed. Wiley-Liss, New York, NY.
Soo, K.C., Spiro, R.H., King, W., Harvey, W., Strong, E.W., 1988. Squamous carcinoma of the gums. Am. J. Surg., 156(4):281–285. [doi:10.1016/S0002-9610(88)80292-7]
Takahashi, O., Hamada, J., Abe, M., Hata, S., Asano, T., Takahashi, Y., Tada, M., Miyamoto, M., Kondo, S., Moriuchi, T., 2007. Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma. Oncol. Rep., 17(4):753–760.
van Dijk, M.A., Peltenburg, L.T., Murre, C., 1995. Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2. Mech. Dev., 52(1):99–108. [doi:10.1016/0925-4773(95)00394-G]
Yamamoto, S., Tomita, Y., Hoshida, Y., Takiguchi, S., Fujiwara, Y., Yasuda, T., Yano, M., Nakamori, S., Sakon, M., Monden, M., et al., 2003. Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J. Clin. Oncol., 21(13):2537–2544. [doi:10.1200/JCO.2003.12.102]
Yamamoto, S., Tomita, Y., Hoshida, Y., Toyosawa, S., Inohara, H., Kishino, M., Kogo, M., Nakazawa, M., Murakami, S., Iizuka, N., et al., 2004a. Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma. Ann. Oncol., 15(9): 1432–1438. [doi:10.1093/annonc/mdh354]
Yamamoto, S., Tomita, Y., Hoshida, Y., Iizuka, N., Monden, M., Yamamoto, S., Iuchi, K., Aozasa, K., 2004b. Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma. Ann. Surg. Oncol., 11(7):697–704. [doi:10.1245/ASO.2004.10.018]
Yamamoto, S., Tomita, Y., Hoshida, Y., Iizuka, N., Kidogami, S., Miyata, H., Takiguchi, S., Fujiwara, Y., Yasuda, T., Yano, M., et al., 2004c. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin. Cancer Res., 10(16): 5558–5565. [doi:10.1158/1078-0432.CCR-0723-03]
Yokoo, S., Umeda, M., Komatsubara, H., Shibuya, Y., Komori, T., 2002. Evaluation of T-classifications of upper gingival and hard palate carcinomas—a proposition for new criterion of T4. Oral Oncol., 38(4):378–382. [doi:10.1016/S1368-8375(01)00077-X]
Author information
Authors and Affiliations
Corresponding author
Additional information
Project (No. 30801382) supported by the National Natural Science Foundation of China
Rights and permissions
About this article
Cite this article
Qiu, Y., Wang, Zl., Jin, Sq. et al. Expression level of pre-B-cell leukemia transcription factor 2 (PBX2) as a prognostic marker for gingival squamous cell carcinoma. J. Zhejiang Univ. Sci. B 13, 168–175 (2012). https://doi.org/10.1631/jzus.B1100077
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B1100077